An Australian woman, Anna Gallo, reportedly fell critically ill and slipped into a coma during a skiing vacation in Japan after contracting a meningococcal infection, according to reports by People.
The Queensland woman was traveling in Japan when she developed sudden symptoms that rapidly worsened. As reported by ABC News, on the last day of the trip, Gallo felt uneasy and started vomiting and fainted in the bathroom. Soon red rashes started appearing all over her body and she was taken to hospital in an ambulance by her partner. Doctors in Tokyo's National Center for Global Health and Medicine diagnosed her with Meningococcal B disease and later she fell into a coma after developing septic shock, a life-threatening complication of infection.
People magazine reported that her condition deteriorated quickly, highlighting the aggressive nature of invasive meningococcal disease. She remained 3 days in a coma. She is sustained with lesions on her legs from the septic shock, which will eventually heal but with heavy scarring.
Meningococcal disease is caused by the bacterium Neisseria meningitidis. It can lead to:
Meningitis (infection of the protective membranes covering the brain and spinal cord)
Septicemia (bloodstream infection)
Septic shock, when infection triggers widespread inflammation and dangerously low blood pressure
The disease can progress rapidly and may become life-threatening within hours.
According to the Centers for Disease Control and Prevention (CDC), symptoms may include:
Sudden fever
Severe headache
Stiff neck
Nausea or vomiting
Sensitivity to light
Confusion
Fatigue
Cold hands and feet
Dark purple skin rash (in septicemia cases)
In severe infections, bacteria entering the bloodstream can trigger septic shock, characterized by:
Very low blood pressure
Organ dysfunction
Rapid heart rate
Altered mental state
Early recognition and urgent medical treatment are critical to improving survival outcomes.
The CDC identifies several risk factors associated with increased susceptibility:
Infants and adolescents/young adults
Living in close quarters (e.g., dormitories, military barracks)
Travelers to regions with high meningococcal prevalence
Individuals with weakened immune systems
People without a functioning spleen
Laboratory workers exposed to N. meningitidis
Exposure during outbreaks
Although meningococcal disease is relatively rare, outbreaks can occur in communal or travel settings.
Vaccination remains the most effective preventive strategy.
The CDC recommends meningococcal vaccines for:
Adolescents (routine vaccination at 11–12 years, booster at 16 years)
Individuals at increased risk
Travelers to high-risk regions
There are different types of meningococcal vaccines, including:
MenACWY vaccines (protect against serogroups A, C, W, Y)
MenB vaccines (protect against serogroup B)
The meningococcal B vaccine (MenB) is specifically recommended for certain age groups and high-risk individuals.
Vaccines significantly reduce the risk of invasive disease but do not protect against all serogroups.
References
Centers for Disease Control and Prevention (CDC). 2024. Meningococcal Vaccination: What Everyone Should Know. Reviewed August 15, 2024. https://www.cdc.gov/meningococcal/about/index.html.
Centers for Disease Control and Prevention (CDC). 2024. Meningococcal B Vaccine Information Statement (VIS). Reviewed August 6, 2024. https://www.cdc.gov/vaccines/hcp/current-vis/meningococcal-b.html.
(Rh)
